Related Experiment Video
Updated: May 15, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel node biopsy for breast cancer: past, present, and future
1Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka, 537-8511, Japan, motomurak@hotmail.com.
Breast Cancer (Tokyo, Japan)
|December 20, 2012
Summary
Sentinel node biopsy is the standard for early breast cancer staging, reducing morbidity. New imaging techniques may help spare more patients from sentinel node biopsy.
Area of Science:
- Oncology
- Radiology
- Surgical Pathology
Background:
- Sentinel node biopsy (SNB) is the standard of care for axillary staging in early breast cancer, replacing axillary lymph node dissection (ALND).
- SNB offers high accuracy with reduced morbidity compared to ALND, sparing most patients unnecessary axillary surgery.
- Several aspects of SNB remain under debate, including the management of micrometastases and positive sentinel nodes.
Purpose of the Study:
- To review current practices and ongoing debates in sentinel node biopsy for breast cancer.
- To introduce and evaluate superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging for sentinel node metastasis detection.
Main Methods:
- Review of existing literature on sentinel node biopsy techniques and controversies.
- Evaluation of SPIO-enhanced MR imaging combined with computed tomography (CT)-lymphography (CT-LG) for sentinel node analysis.
Main Results:
- Sentinel node biopsy is a less-morbid alternative to axillary lymph node dissection for early breast cancer.
- SPIO-enhanced MR imaging demonstrates utility in detecting metastases within sentinel nodes identified by CT-LG.
- This imaging approach may allow patients with disease-free sentinel nodes to avoid SNB altogether.
Conclusions:
- Sentinel node biopsy is a well-established, less-morbific procedure for breast cancer staging.
- SPIO-enhanced MR imaging shows promise for improving the accuracy of sentinel node assessment and potentially reducing the need for biopsy in select cases.
